News

NCVTC to develop of host-directed antivirals for COVID-19

The selected candidates with anti-coronavirus activity will be subjected to study their molecular mechanism of action, besides examining generation of potential drug-resistant virus variants.

Jun 05, 2020

By : Team ABLE

ABLE Chairperson & Biocon Founder Kiran Mazumdar-Shaw is the EY World Entrepreneur of the year 2020

She is the third Indian to win this prestigious global award after Mr N R Narayana Murthy of Infosys (2005) and Mr Uday Kotak of Kotak Mahindra Bank (2014). Dr Kiran Mazumdar-Shaw was chosen the winner from among 46 entrepreneurs from 41 countries by the global management consultancy, EY. The award was announced during a virtual conference on June 4, 2020

Jun 05, 2020

By : Team ABLE

AstraZeneca joins Serum Institute to supply 1 billion doses of COVID-19 vaccine

AstraZeneca also announces $750 million agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) and GAVI

Jun 05, 2020

By : Team ABLE

IIT Alumni launches MegaLab, a global Genetic Testing Lab initiative

A Global Competition is being launched to finalize the operating, technology and funding partners for the MegaLab Mumbai initiative.

Jun 04, 2020

By : Team ABLE

Serum Institute commits to ramp up HPV vaccines supply

On the eve of the Global Vaccine Summit 2020, five manufacturers committed to increasing and prioritising HPV vaccine supply to Gavi-supported countries, which have among the highest cervical cancer burdens in the world. Manufacturers target to immunize at least 84 million girls in Gavi countries

Jun 04, 2020

By : Team ABLE